A self-care smartphone application for midlife women with menopausal symptoms: A proof-of-concept study - Scorecard - MDSpire

A self-care smartphone application for midlife women with menopausal symptoms: A proof-of-concept study

  • By

  • Takuma Ohsuga

  • Miho Egawa

  • Kaori Tsuyuki

  • Miki Ohtsuki

  • Yu Wanjie

  • Shi Juan

  • Rena Hinotani

  • Yoshimitsu Takahashi

  • Takeo Nakayama

  • Masaki Mandai

  • June 10, 2026

  • 0 min

Share

Clinical Scorecard: A smartphone app for self-management of menopausal symptoms in midlife women: A preliminary study

At a Glance

CategoryDetail
Condition
Key MechanismsSelf-care support through symptom tracking and personalized healthcare recommendations (source needed).
Target Population
Care Setting

Key Highlights

  • Remove 'Potential for digital health solutions to improve accessibility and clinical efficiency' unless directly supported.

Guideline-Based Recommendations

Diagnosis

    Management

    • Ensure all strategies are directly cited from the source.

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        Clarify that insights are based on the study's findings.

        Clinical Best Practices

        • Remove unsupported recommendations.

        Related Resources & Content

        Original Source(s)

        A self-care smartphone application for midlife women with menopausal symptoms: A proof-of-concept study

        • by Takuma Ohsuga, Miho Egawa, Kaori Tsuyuki, Miki Ohtsuki, Yu Wanjie, Shi Juan, Rena Hinotani, Yoshimitsu Takahashi, Takeo Nakayama, Masaki Mandai

        • June 10, 2026

        Related Content

        Perceived stress and mental health in perimenopausal women: a serial mediation study of psychological distress and social support

        GLP-1 Drugs Tied to Lower Addiction Risk

        In a target-trial emulation of more than 600,000 veterans, GLP-1 RA initiators saw fewer new substance use disorders—and patients with existing SUDs had fewer overdoses, hospitalizations, and deaths.

        Analysis of mortality risk and influencing factors in female patients with young-onset type 2 diabetes